- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Global University Venturing
Tenaya tends to $180m IPO
The GV-backed cardiovascular therapeutics company has priced an upsized offering on Nasdaq, with the shares closing just marginally higher on the first day.
Aug 2, 2021IN8Bio initiates $40m IPO
IN8Bio, a University of Alabama spinout and cancer immunotherapy developer, has pulled in $40m through its IPO.
Jul 31, 2021Daily deal net: July 30, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Jul 30, 2021Deep Genomics jumps into $180m series C
University of Toronto-linked Deep Genomics has picked up $180m in its series C round led by SoftBank Vision Fund 2.
Jul 30, 2021Niron Magnetics attracts $21.3m
University of Minnesota spinout Niron Magnetics has collected $21.3m in funding to build a pilot production facility for its rare earth-free magnets.
Jul 30, 2021IgGenix initiates $25m series A1
Co-founded by Stanford researchers, IgGenix is working on therapies that address severe allergies.
Jul 29, 2021IP Group’s US unit raises $58.6m
The commercialisation firm’s US operation confirmed it raised $58.6m during the first half of the year, although it had already disclosed $50m of this previously.
Jul 29, 2021Tepha ticks acquisition box
Based on research originally conducted at MIT, Tepha has been purchased by BD for an undisclosed sum.
Jul 29, 2021Croatia and Slovenia gain $48m fund
The European Investment Fund has partnered two banks to launch an investment platform that aims to support the creation of 100 spinouts.
Jul 29, 2021Isar Aerospace increases series B payload
TU Munich spinout Isar Aerospace has added $75m to its series B round, bringing the round’s total to nearly $166m and its overall financing to more than $183m.
Jul 29, 2021Ring circles $117m series B
UPMC Enterprises has contributed to a $117m series B round for gene therapy developer Ring Therapeutics.
Jul 29, 2021Featured Content
University Venture Funds: The ListThe definitive list of university venture funds around the worldUniversity Venture Funds: The List
The definitive list of university venture funds around the world
Special ReportCorporate collaboration with universities: How to commercialise innovative researchSpecial Report
Corporate collaboration with universities: How to commercialise innovative research
Beyond the Breakthrough PodcastExplore the BTB podcast archive with the world's brightest minds in university innovation answering the question: how does research make it from a lab into the real world?Beyond the Breakthrough Podcast
Explore the BTB podcast archive with the world's brightest minds in university innovation answering the question: how does research make it from a lab into the real world?
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation


